Amarin Corp Plc (AMRN)

[heysfguy]

Nofan: "You can continue to blame the government for every bit of bad news. OR You can start blaming Management."

OR, you can probably do better by assigning blame around where its appropriate. Certainly management has not been perfect, but neither has the FDA. There's a lot of blame to go around.

It's all about where we go from here, and - I agree with you - it's about selling the product.

I don't blame doctors for being reticent to write prescriptions for a new EPA product, even if it's "best in class." This I believe is due to a wide range of issues, including education, uncertainty on behalf of leadership organizations, all sorts of conflicting studies, and a plethora of approaches to cardiovascular health issues. (Just yesterday my cardiologist told me he now believes mere dietary changes - cutting out wheat, rice and such - are going to do the trick for me, in addition to my low dose statin regimen!)

I'm hoping there will continue to be - in addition to ANCHOR study - plenty of new studies about the benefits of trying a purified form of EPA. JL has repeatedly pointed out the inflammation angle on this chemical, and if it holds true, this ultimately will be more about anti-inflammatory properties of Vascepa beyond just the CV market.

Management's most recent communication may indicate they are going to concentrate efforts going forward on increasing sales in order to bridge the current "valley of death" mode currently illustrated by the PPS. I am hoping Management has figured out various plans for long term growth.